Table 4.
Presence of symptoms, classification of celiac serology and Marsh grading of biopsy histology before and after treatment with Gluten Contamination Elimination Diet
|
Symptoms |
Pre-Diet: n (%) |
Post-Diet: n (%) |
| Asymptomatic |
1 (6%) |
14 (82%) |
| Symptomatic |
16 (94%) |
3 (18%) |
|
Histology |
Pre-Diet: n (%) |
Post-Diet: n (%) |
| Biopsy obtained |
12 (71%) |
5 (29%) |
| Marsh 3 |
7 |
1 |
| Marsh 2 |
2 |
|
| Marsh 0-1 |
3 |
4 |
|
Celiac Serology1 |
Pre-Diet: n (%) |
Post-Diet: n (%) |
| High celiac serology |
10 (59%) |
2 (12%) |
| Weak positive celiac serology |
3 (18%) |
5 (30%) |
| Negative celiac serology | 4 (24%) | 10 (59%) |
1 Celiac serology defined as negative, weak positive or high using the cut-offs provided by the ELISA kit manufacturer. Tissue transglutaminase (tTG) IgA was followed in 16/17 patients; anti-endomysial (EMA) IgA was followed in the remaining patient.